Tandem Diabetes Care (Nasdaq:TNDM) announced today that the FDA cleared its Tandem Mobi automated insulin delivery system.
Gabrielle Schmid, RD, CDE, CPT on LinkedIn: #vasc23 #t1d
Bill Thomasson posted on LinkedIn
Emina Ibrahimbegovic on LinkedIn: FDA clears Tandem Mobi durable
These diabetes devices are set to launch in 2024
FDA Clears Tandem's Mobi Insulin Pump for Ages 2+
Kassidy Mooney RN, BSN on LinkedIn: Insulet Announces FDA
Allison Dale posted on LinkedIn
FDA Clears Tandem's Mobi Insulin Pump for Ages 2+
Savvy Updates, 10/30/23: Omnipod 5 Cleared for iPhone, Tandem Mobi
Tandem Diabetes launches clinical trial for its automatic insulin
Allison Mitchell posted on LinkedIn
Savvy Updates, 7/17/23: Tandem Mobi APPROVED, Insulet 510k Filing
Community Blog - Meeting the Patch Pump Challenge
